Loading
Latest filing published 29 Aug 2023 for VirExit Technologies, Inc., €9,237.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by James C. Katzaroff span 2 companies, the busiest being GlobeStar Therapeutics Corp and VirExit Technologies, Inc. Between 3 April 2023 and 28 August 2023, the trades on record add up to 3 filings.
No open-market sale appears; the market trades are 1 purchase worth €9,237. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 29 August 2023 came the latest disclosure, an open-market purchase for €9,237 in VirExit Technologies, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations